Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1673

1.

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group.

J Am Coll Cardiol. 2008 Dec 2;52(23):1834-43. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7.

2.

Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.

Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C; REVERSE Study Group.

J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1.

4.

Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.

Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ.

Am J Cardiol. 2006 Jul 15;98(2):230-5. Epub 2006 May 19.

PMID:
16828599
5.

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group.

Circulation. 2004 Nov 2;110(18):2864-8. Epub 2004 Oct 25.

6.

Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.

Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS.

Am J Cardiol. 2007 Jul 1;100(1):90-3. Epub 2007 May 15.

PMID:
17599447
7.

Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).

Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC; REVERSE study group.

Eur Heart J. 2011 Jul;32(13):1631-9. doi: 10.1093/eurheartj/ehq408. Epub 2010 Nov 25.

PMID:
21112898
8.

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias.

Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG.

J Am Coll Cardiol. 2003 Oct 15;42(8):1454-9.

9.

Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.

De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR.

J Card Fail. 2008 Feb;14(1):9-18. doi: 10.1016/j.cardfail.2007.08.003.

PMID:
18226768
10.

The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.

Ng K, Kedia N, Martin D, Tchou P, Natale A, Wilkoff B, Starling R, Grimm RA.

Pacing Clin Electrophysiol. 2007 Feb;30(2):193-8.

PMID:
17338715
11.

Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.

Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A.

Ital Heart J. 2004 May;5(5):364-70.

PMID:
15185900
12.

Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.

Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ.

J Am Coll Cardiol. 2004 Nov 2;44(9):1834-40.

13.

Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.

Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M.

Circulation. 2007 Jan 16;115(2):204-12. Epub 2006 Dec 26.

14.

Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).

Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A, Bianchi S, Laurenzi F, Curnis A, Vincenti A, Valsecchi S, Denaro A; InSync/InSync ICD Italian Registry Investigators.

Am J Cardiol. 2007 Sep 15;100(6):1007-12. Epub 2007 Jul 5.

PMID:
17826388
15.

Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.

Adabag S, Roukoz H, Anand IS, Moss AJ.

J Am Coll Cardiol. 2011 Aug 23;58(9):935-41. doi: 10.1016/j.jacc.2011.05.022. Review.

16.

Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.

Linde C, Gold MR, Abraham WT, St John Sutton M, Ghio S, Cerkvenik J, Daubert C; REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction Study Group.

Eur Heart J. 2013 Sep;34(33):2592-9. doi: 10.1093/eurheartj/eht160. Epub 2013 May 2.

PMID:
23641006
17.

Cardiac resynchronization therapy in patients with a narrow QRS complex.

Bleeker GB, Holman ER, Steendijk P, Boersma E, van der Wall EE, Schalij MJ, Bax JJ.

J Am Coll Cardiol. 2006 Dec 5;48(11):2243-50. Epub 2006 Nov 9.

18.

Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study.

Fung JW, Zhang Q, Yip GW, Chan JY, Chan HC, Yu CM.

J Cardiovasc Electrophysiol. 2006 Dec;17(12):1288-92. Epub 2006 Sep 20.

PMID:
16987381
19.

Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.

Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB.

J Med Assoc Thai. 2007 Jul;90(7):1458-66.

PMID:
17710992
20.

Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study.

Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB.

J Interv Card Electrophysiol. 2005 Mar;12(2):107-13.

PMID:
15744462

Supplemental Content

Support Center